CARLSMED, INC.
No enriched coverage for $CARL in the last 7 days.
No SEC Form 4 filings for $CARL in the last 30 days.
The article provides financial information for Carlsmed, Inc. (LS:A41CM7) on TradingView. It shows the total operating expenses for the company, accessible through various financial data providers like ICE Data Services and FactSet. The content primarily focuses on the display of operating expenses within the TradingView platform.
This page provides financial statistics for Carlsmed, Inc. (LS:A41CM7), a company listed on the Lang & Schwarz Tradecenter. It details various annual and quarterly key financial stats and ratios, including valuation, profitability, liquidity, solvency ratios, and per-share metrics, although most data fields are currently listed as unavailable. The page serves as a hub for users to find market capitalization, P/E Ratio, EPS, ROI, and other financial information for Carlsmed.
Carlsmed, Inc. (NASDAQ:CARL) experienced a significant 26.4% drop in short interest in April, with the total short interest falling to 571,356 shares. Institutional investors have increased their holdings in the company, with OrbiMed Advisors LLC, Janus Henderson Group PLC, and Vanguard Group Inc. initiating or adding to their positions. Despite a "Hold" consensus rating and a target price of $19.67, analyst sentiment is mixed, with some firms trimming price targets while others maintain "Buy" ratings.
